J A Menchaca, S Lefkowitz. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » HumansHyperlipoproteinemias/immunologyImmunity, CellularLipoproteins, VLDL/immunologyLymphocyte ActivationNephrotic Syndrome/etiologyNephrotic Syndrome/immunology
Substances： See more » Lipoproteins, VLDL
Year: 1980 PMID： 6103416 DOI： 10.1016/s0140-6736(80)91524-x
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321